Fingolimod – Articles Page
Aburaihan Pharmaceutical Company
Product Information
Approval Package
| 1 | Administrative Document(s) & Correspondence | EN | - | Download |
| 2 | Approval Letter | EN | - | Download |
| 3 | Chemistry review | EN | - | Download |
| 4 | Clinical Pharmacology Biopharmaceutics Review | EN | - | Download |
| 5 | Cross Discipline Team Leader Review | EN | - | Download |
| 6 | Medical Review | EN | - | Download |
| 7 | Other Review | EN | - | Download |
| 8 | Pharmacology review | EN | - | Download |
| 9 | printed labeling | EN | - | Download |
| 10 | Proprietary Name Review | EN | - | Download |
| 11 | Risk Assessment and Risk Mitigation Review | EN | - | Download |
| 12 | Risk Evaluation and Mitigation Strategy(REMS) | EN | - | Download |
| 13 | Statistical review | EN | - | Download |
| 14 | Summary Review | EN | - | Download |
Review Article
| 1 | Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis | 2015 | EN | Dovepress | Download |
| 2 | Fingolimod A Review of its Use in the Management of Relapsing-Remitting Multiple Sclerosis | 2011 | EN | Scott | Download |
| 3 | review-of-the-safety-efficacy-and-tolerability-of-fingolimo | 2019 | EN | Dovepress | Download |